e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Understanding the immunopathology that underlies airway obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The new approach to understand the role of IL-15 and BMP proteins in asthma remodelling based on methacholine challenge test evidence.
M. Kocwin (Lodz, Poland), M. Jonakowski (Lodz, Poland), L. Mokros (Lodz, Poland), M. Panek (Lodz, Poland), J. Szemraj (Lodz, Poland), P. Kuna (Lodz, Poland)
Source:
International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Session:
Understanding the immunopathology that underlies airway obstructive diseases
Session type:
Poster Discussion
Number:
4997
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kocwin (Lodz, Poland), M. Jonakowski (Lodz, Poland), L. Mokros (Lodz, Poland), M. Panek (Lodz, Poland), J. Szemraj (Lodz, Poland), P. Kuna (Lodz, Poland). The new approach to understand the role of IL-15 and BMP proteins in asthma remodelling based on methacholine challenge test evidence.. 4997
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
B cells are crucial in the regulation of airway hyperreactivity in an experimental model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
IL-13-induced cytokine release and hyperresponsiveness in precision cut lung slices of different species – Characterization of a model potentially suitable for translational research of asthma cellular events
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
A hypothesis driven approach investigating the interleukin-6 pathway in UBIOPRED severe asthma patients
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Can lung function tests help identify functional phenotypes in children with asthma?
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021
The expression of interleukin-13 gene is regulated by nfat1 in human T cells
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
Are we ready to monitor inflammation and remodelling in asthma?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Oral presentation: Altered airway epithelial gene expression determines the lung remodeling response to environmental allergens; role of activin
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
T-cell mediated inflammation is is not required for sustained AHR that persists in mice following chronic allergen challenge
Source: Eur Respir J 2003; 22: Suppl. 45, 482s
Year: 2003
Mannitol challenge testing in clinical practice and its role in identifying aiways hyperreactivity
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
A study to assess airway remodelling and the utility of low dose CT scoring to evaluate the asthmatic airway.
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Do bacteria have a role in asthma development?
Source: Eur Respir J 2010; 36: 469-471
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept